ConductScience.org, home

Paper159127

Platinate toxicity: past, present, and prospects.

Guarino AM and 7 others. Cancer Treat Rep, 1979. Cited by 135 papers, by iCite.

Cite this record

ConductScience Library. Platinate toxicity: past, present, and prospects. Papers, record 159127. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/159127

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platinate toxicity: past, present, and prospects.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
135
iCite
Relative citation ratio, by iCite
6.43
iCite
Revised in PubMed
2013-11-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guarino AMA M
2Miller DSD S
3Arnold STS T
4Pritchard JBJ B
5Davis RDR D
6Urbanek MAM A
7Miller TJT J
8Litterst CLC L

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
KidneyMajor topic
Organoplatinum CompoundsMajor topic
Adenosine Triphosphatases
Animals
Cyclohexylamines
Dogs
Drug Evaluation, Preclinical
Ear, Inner
Fishes
Furosemide
Haplorhini
Humans
Kidney Tubules
Male
Mice
Rats
Species Specificity

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.

PMIDTitleJournalYearIn PapersSource
28393095Profound sensorineural hearing loss after one cycle of intraperitoneal cisplatin in treatment of advanced ovarian cancer.Gynecol Oncol Rep2017https://conductscience.org/library/papers/28393095PubMed
24858035Protective role of C-phycocyanin against secondary changes during sodium selenite mediated cataractogenesis.Nat Prod Bioprospect2014https://conductscience.org/library/papers/24858035PubMed
21455790Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.Neurotox Res2011https://conductscience.org/library/papers/21455790PubMed
20467916
Investigation of the efficacy of 99 mTc-DTPA scintigraphic GFR measurement with Gates method in the detection of cisplatin-induced nephrotoxicity in comparison with plasma urea and creatinine measurement.
Med Oncol2011https://conductscience.org/library/papers/20467916PubMed
8396389Effects of cisplatin and ORG.2766 in chick embryonic brain cell cultures.Arch Toxicol1993https://conductscience.org/library/papers/8396389PubMed
7050733Current trends in safety testing and toxicological research.Naturwissenschaften1982https://conductscience.org/library/papers/7050733PubMed
6540631Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6540631PubMed
6254081Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6254081PubMed
6241789Cisplatinum: a review, with special reference to cellular and molecular interactions.Agents Actions1984https://conductscience.org/library/papers/6241789PubMed
4040567Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.J Pharmacokinet Biopharm1985https://conductscience.org/library/papers/4040567PubMed
3908127Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3908127PubMed
3698175Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3698175PubMed
3436343Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kinetics.Eur J Drug Metab Pharmacokinet1987https://conductscience.org/library/papers/3436343PubMed
3395246Nephrotoxicity screening in rats: a validation study.Arch Toxicol1988https://conductscience.org/library/papers/3395246PubMed
3395245Nephrotoxicity screening in rats; general approach and establishment of test criteria.Arch Toxicol1988https://conductscience.org/library/papers/3395245PubMed
3297665Aquatic models for the study of renal transport function and pollutant toxicity.Environ Health Perspect1987https://conductscience.org/library/papers/3297665PubMed
3045443Mechanisms of cellular resistance to cisplatin.Med Oncol Tumor Pharmacother1988https://conductscience.org/library/papers/3045443PubMed
2990752The effect of cisplatin on renal ATPase activity in vivo and in vitro.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/2990752PubMed
2909288Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2909288PubMed
2500265Zinc acetate pretreatment ameliorates cisplatin-induced Sertoli cell dysfunction in Sprague-Dawley rats.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2500265PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/159127

GET https://conductscience.org/api/papers/v1/159127/cited_by?page=2